Literature DB >> 22534781

Can a two-faced kinase be exploited for osteosarcoma?

James R Woodgett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22534781      PMCID： PMC4485463          DOI： 10.1093/jnci/djs223

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  13 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 2.  When pathways collide: collaboration and connivance among signalling proteins in development.

Authors:  Helen McNeill; James R Woodgett
Journal:  Nat Rev Mol Cell Biol       Date:  2010-05-12       Impact factor: 94.444

3.  Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines.

Authors:  Bradley W Doble; Satish Patel; Geoffrey A Wood; Lisa K Kockeritz; James R Woodgett
Journal:  Dev Cell       Date:  2007-06       Impact factor: 12.270

4.  Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase.

Authors:  N Embi; D B Rylatt; P Cohen
Journal:  Eur J Biochem       Date:  1980-06

5.  Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

Authors:  K P Hoeflich; J Luo; E A Rubie; M S Tsao; O Jin; J R Woodgett
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

6.  Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.

Authors:  Kris A Steinbrecher; Willie Wilson; Patricia C Cogswell; Albert S Baldwin
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

7.  Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling.

Authors:  V W Ding; R H Chen; F McCormick
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

8.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

Authors:  A A Beg; W C Sha; R T Bronson; S Ghosh; D Baltimore
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

9.  Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism.

Authors:  Katrina MacAulay; Bradley W Doble; Satish Patel; Tanya Hansotia; Elaine M Sinclair; Daniel J Drucker; Andras Nagy; James R Woodgett
Journal:  Cell Metab       Date:  2007-10       Impact factor: 27.287

10.  Does GSK-3 provide a shortcut for PI3K activation of Wnt signalling?

Authors:  Daniel Voskas; Ling S Ling; James R Woodgett
Journal:  F1000 Biol Rep       Date:  2010-11-24
View more
  5 in total

1.  Fine-Tuning of the RIG-I-Like Receptor/Interferon Regulatory Factor 3-Dependent Antiviral Innate Immune Response by the Glycogen Synthase Kinase 3/β-Catenin Pathway.

Authors:  Kashif Aziz Khan; Florence Dô; Alexandre Marineau; Priscilla Doyon; Jean-François Clément; James R Woodgett; Bradley W Doble; Marc J Servant
Journal:  Mol Cell Biol       Date:  2015-06-22       Impact factor: 4.272

2.  GSK-3α promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-κB.

Authors:  Deepali Bang; Willie Wilson; Meagan Ryan; Jen Jen Yeh; Albert S Baldwin
Journal:  Cancer Discov       Date:  2013-04-01       Impact factor: 39.397

3.  GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1/3/4.

Authors:  Xiaodong Huo; Shu Liu; Ting Shao; Hui Hua; Qingbin Kong; Jiao Wang; Ting Luo; Yangfu Jiang
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

4.  Glycogen synthase kinase 3 protein kinase activity is frequently elevated in human non-small cell lung carcinoma and supports tumour cell proliferation.

Authors:  Emma E Vincent; Douglas J E Elder; Linda O'Flaherty; Olivier E Pardo; Piotr Dzien; Lois Phillips; Carys Morgan; Joya Pawade; Margaret T May; Muhammad Sohail; Martin R Hetzel; Michael J Seckl; Jeremy M Tavaré
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

5.  The natural agent rhein induces β-catenin degradation and tumour growth arrest.

Authors:  Shu Liu; Jiao Wang; Ting Shao; Peiying Song; Qingbin Kong; Hui Hua; Ting Luo; Yangfu Jiang
Journal:  J Cell Mol Med       Date:  2017-10-11       Impact factor: 5.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.